About 51,000 results
Open links in new tab
  1. AstraZeneca | Cafepharma

    Dec 15, 2025 · After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a particular type of breast cancer, the companies have scored …

  2. AstraZeneca | Cafepharma

    Dec 19, 2025 · AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US in light of FDA concerns over clotting complications – including deaths – in people taking …

  3. baxdrostat | Cafepharma

    Dec 3, 2025 · AstraZeneca's baxdrostat has hit the mark in another phase 3 trial involving people who struggle to control their blood pressure with current therapies, keeping the would-be blockbuster on …

  4. Caprelsa | Cafepharma

    Aug 23, 2023 · Caprelsa AstraZeneca sells rare cancer drug to Sanofi for up to $300 million Submitted by admin on Mon, 07/27/2015 - 10:00 Read more about AstraZeneca sells rare cancer drug to Sanofi …

  5. Airsupra | Cafepharma

    Sep 26, 2025 · AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. AstraZeneca Direct will go …

  6. AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …

    Aug 1, 2022 · Anonymous board for AstraZeneca.Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only …

  7. Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab …

    Feb 23, 2025 · Anonymous board for Pfizer.Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only …

  8. capivasertib | Cafepharma

    Oct 26, 2022 · So Astrazeneca’s news of a win with its contender camizestrant in ER-positive, Her2-negative breast cancer today came as a surprise. Not only that, but Astra today scored a second …

  9. July 24 2025 - AstraZeneca drug acquired in Alexion deal succeeds in ...

    Jul 24, 2025 · AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis to pay …

  10. Arcutis Biotherapeutics | Cafepharma

    Nov 18, 2022 · Arcutis Biotherapeutics is on a roll. Months after launching its topical formulation of an old AstraZeneca drug in plaque psoriasis, the company is touting positive Phase III data in atopic …